selected publications
-
Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
Current treatment options in oncology.
2018
Information Resource
GET IT
Times cited: 11 -
Atypical autoimmune adverse effects with checkpoint blockade therapies.
Annals of oncology : official journal of the European Society for Medical Oncology.
2017
Editorial Article
GET IT
Times cited: 10 -
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab.
Journal of the National Cancer Institute.
2016
Academic Article
GET IT
Times cited: 56 -
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A Review.
JAMA oncology.
2016
Information Resource
GET IT
Times cited: 387